Table 1.
HCM clinical and CMR characteristics
| Mean (Range or % Patients) | |
|---|---|
|
Age (years) |
45 (25–59) |
|
Women |
4 (17) |
|
BMI
*
(kg/m
2
) |
26 (14–47) |
|
Maximum hypertrophy (mm) |
23 (16–32) |
|
# Hypertrophied segments ≥ 15 mm |
4.5 (2–9) |
|
Presence SAM
‡
|
13 (62) |
|
Presence MR
§
|
13 (57) |
|
Presence LGE
||
|
20 (83) |
|
LV EF
¶
(%) |
66 (58–81) |
|
LVEDV
#
(mL) |
160 (56–285) |
|
LVEDVI
**
(mL/m
2
) |
80 (43–134) |
| Presence LA † dilation | 14 (70) |
* BMI = body mass index; †LA = left atrium; #LVEDV = left ventricle end diastolic volume; **LVEDI = left ventricle end diastolic volume index; ¶LV EF = left ventricle ejection fraction; ||LGE = late gadolinium enhancement; §MR = mitral regurgitation; ‡SAM = systolic anterior motion.